Help researchers learn more about coronavirus by joining the Propel clinical research study!

COVID-19 is an infectious disease that has impacted communities all over the world. Symptoms can range from mild symptoms that do not require hospitalization to severe symptoms that require intensive care. Researchers are currently learning as much as they can to find safe and effective therapy options.

The goal of the Propel study is to see how safe and effective the study drug, zotatifin, is at helping prevent people with mild to moderate COVID-19 from advancing to severe COVID-19.

Scroll to top